Rising Pressure to Curb Healthcare Spending
The life science analytics market is projected to reach USD 47.5 billion by 2027 from USD 27.1 billion in 2022, at a CAGR of 11.8% during the forecast period. Growth in this market is mainly driven by rising pressure to curb healthcare spending, the rising need for improved data standardization, and the increasing adoption of analytical solutions in clinical trials. On the other hand, a high implementation price is expected to restrain the growth of this market.
Descriptive analytics type segment holds the largest share of the life science analytics market in 2021
On the basis of type, the life science analytics market is bifurcated into descriptive, predictive, and prescriptive analytics. The descriptive analytics segment accounted for the largest market share in 2021. Due to its ability to confirm the synergistic integration of predictions and prescriptions, prescriptive analytics segment is projected to grow at the highest CAGR during the forecast period.
Services segment accounted for the largest share of the life science analytics market in 2021
On the basis of component, the life science analytics market is bifurcated into services and software. The services segment accounted for the largest market share in 2021 and is expected to register the highest growth during the forecast period. The large share and high growth in this segment can be attributed to the frequent need for services such as software upgrades and maintenance.
Asia Pacific to be the fastest-growing regional market in 2021
On the basis of region, the life science analytics market is bifurcated into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2021, North America accounted for the largest market share. The large share of this market is attributed to the strong economies in the US and Canada, which have allowed for considerable investments in technology in this region. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period. Factors such as the rising adoption of advanced technologies, the increasing growth in the life science industry, and the growing focus of major players on increasing their presence in emerging APAC countries are expected to drive market growth in this regional segment.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 (32%), Tier 2 (44%), and Tier 3 (24%)
- By Designation: C-level (30%), D-level (34%), and Others (36%)
- By Region: North America (40%), Europe (28%), Asia Pacific (20%), and the RoW (12%)
Prominent players in this market include Oracle (US), IBM (US), SAS Institute Inc. (US), Accenture (Ireland), IQVIA Inc, (US), Cognizant (US), Wipro (India), Allscripts Healthcare, LLC (US), Optum, Inc. (US), Microsoft (US), MaxisIT (US), ExlService Holdings, Inc. (US), Cerner Corporation (US), Cotiviti, Inc. (US), Inovalon (US), CitiusTech Inc (US), Saama Technologies, LLC. (US), Axtria (US), Clarivate (UK), ThoughtSphere (US), ThoughtSpot Inc. (US), Alteryx, Inc. (US), Sisense Inc. (US), Amazon Web Services, Inc., and Veeva Systems (US).
Research Coverage:
This report provides a picture of the life science analytics market. It aims at estimating the size and future growth potential of the market across different segments, such as type, component, deployment model, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall life science analytics market and its subsegments. This report will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, challenges, and opportunities.
Table of Contents
1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.2.1 Inclusions and Exclusions
1.3 Market Scope
1.3.1 Markets Covered
Figure 1 Life Science Analytics: Market Segmentation
1.3.2 Years Considered
1.4 Currency Considered
1.5 Stakeholders
1.6 Summary of Changes
1.7 Recession Impact
2 Research Methodology
2.1 Research Data
2.2 Research Methodology Design
Figure 2 Life Science Analytics Market: Research Design
2.2.1 Secondary Sources
2.2.1.1 Key Data from Secondary Sources
2.2.2 Primary Sources
Figure 3 Primary Sources
2.2.2.1 Key Data from Primary Sources
2.2.2.2 Key Industry Insights
Figure 4 Breakdown of Primary Interviews
2.3 Market Size Estimation
Figure 5 Market Size Estimation: Revenue Share Analysis
Figure 6 Global Market: Revenue Share Analysis Illustration
Figure 7 Bottom-Up Approach
Figure 8 Global Market: CAGR Projection from Analysis of Drivers, Restraints, Opportunities, and Challenges (2022-2027)
Figure 9 CAGR Projection: Supply-Side Analysis
Figure 10 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
Figure 11 Data Triangulation Methodology
2.5 Market Share Estimation
2.6 Study Assumptions
2.7 Limitations
2.7.1 Methodology-Related Limitations
2.7.2 Scope-Related Limitations
2.8 Risk Assessment
Table 1 Global Market: Risk Assessment
2.9 Global Market: Recession Impact
3 Executive Summary
Figure 12 Life Science Analytics Market, by Type, 2022 Vs. 2027 (USD Million)
Figure 13 Global Market, by Application, 2022 Vs. 2027 (USD Million)
Figure 14 Global Market, by Component, 2022 Vs. 2027 (USD Million)
Figure 15 Global Market, by Delivery Model, 2022 Vs. 2027 (USD Million)
Figure 16 Global Market, by End-user, 2022 Vs. 2027 (USD Million)
Figure 17 Global Market: Geographical Snapshot
4 Premium Insights
4.1 Global Market Overview
Figure 18 Rising Technological Advancements and Growing Adoption of Analytics Solutions for Clinical Trials to Drive Market
4.2 Global Market, by Type
Figure 19 Descriptive Analytics Segment to Dominate Market in 2021
4.3 Global Market, by End-user & Region
Figure 20 Pharmaceutical & Biotechnology Companies in North America Accounted for Largest Market Share in 2021
4.4 Global Market: Geographic Snapshot
Figure 21 China to Register Highest Growth Rate During Forecast Period
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 22 Life Science Analytics Market: Drivers, Restraints, Opportunities, and Challenges
5.2.1 Drivers
5.2.1.1 Rising Pressure to Curb Healthcare Spending
Figure 23 Healthcare Spending as a Percentage of Gdp, by Country (2019)
5.2.1.2 Rising Need for Improved Data Standardization
5.2.1.3 Rising Technological Advancements in Analytical Solutions
5.2.1.4 Impact of Big Data on Life Science
5.2.1.5 Growing Adoption of Analytical Solutions in Clinical Trials
5.2.1.6 Increasing Adoption of Analytics for Sales & Marketing Applications
5.2.2 Restraints
5.2.2.1 High Implementation Cost of Advanced Analytical Solutions
5.2.2.2 Data Privacy Concerns
5.2.3 Opportunities
5.2.3.1 Growing Focus on Value-Based Care
5.2.3.2 Use of Analytics in Precision & Personalized Medicine
5.2.3.3 Big Data Analytics for R&D Productivity
5.2.4 Challenges
5.2.4.1 Issues Associated with Data Integration
5.2.4.2 Shortage of Skilled Personnel
5.3 Ecosystem Analysis
5.4 Value Chain Analysis
Figure 24 Global Market: Value Chain Analysis
5.5 Porter's Five Forces Analysis
5.5.1 Threat from New Entrants
5.5.2 Threat from Substitutes
5.5.3 Bargaining Power of Suppliers
5.5.4 Bargaining Power of Buyers
5.5.5 Intensity of Competitive Rivalry
5.6 Technology Analysis
5.6.1 Machine Learning
5.6.2 Artificial Intelligence
5.6.3 Internet of Things
5.6.4 Big Data
5.7 Industry Trends
5.7.1 Increasing Partnerships & Collaborations for Innovation
5.7.2 Growing Demand for Ai in Pharmaceutical Industry
5.8 Case Study Analysis
5.8.1 Case Study 1
5.8.2 Case Study 2
5.8.3 Case Study 3
5.9 Regulatory Analysis
5.9.1 North America
5.9.2 Europe
5.9.3 Asia-Pacific
5.9.4 Middle East & Africa
5.9.5 Latin America
5.10 Pricing Analysis
Table 2 Average Selling Price of Life Science Analytics Solutions, by Application
5.10.1 Average Selling Price Trend Analysis
5.11 Key Conferences and Events in 2022-2023
Table 3 Global Market: Detailed List of Conferences and Events
5.12 Key Stakeholders and Buying Criteria
5.12.1 Key Stakeholders in Buying Process
Figure 25 Influence of Stakeholders on Buying Process for End-users
Table 4 Influence of Stakeholders on Buying Process for End-users (%)
5.12.2 Buying Criteria
Figure 26 Key Buying Criteria for End-users
Table 5 Key Buying Criteria for End-users
6 Life Science Analytics Market, by Type
6.1 Introduction
Table 6 Global Market, by Type, 2020-2027 (USD Million)
6.2 Descriptive Analytics
6.2.1 Ability to be Implemented with Standard Aggregate Functions to Drive Market
Table 7 Descriptive Analytics Market, by Region, 2020-2027 (USD Million)
Table 8 North America: Descriptive Analytics Market, by Country, 2020-2027 (USD Million)
Table 9 Europe: Descriptive Analytics Market, by Country, 2020-2027 (USD Million)
Table 10 Asia-Pacific: Descriptive Analytics Market, by Country, 2020-2027 (USD Million)
6.3 Predictive Analytics
6.3.1 Simulations Development for Prediction of Future Trends to Drive Market
Table 11 Predictive Analytics Market, by Region, 2020-2027 (USD Million)
Table 12 North America: Predictive Analytics Market, by Country, 2020-2027 (USD Million)
Table 13 Europe: Predictive Analytics Market, by Country, 2020-2027 (USD Million)
Table 14 Asia-Pacific: Predictive Analytics Market, by Country, 2020-2027 (USD Million)
6.4 Prescriptive Analytics
6.4.1 Real-Time Analysis for Improved Decision-Making to Support Market Growth
Table 15 Prescriptive Analytics Market, by Region, 2020-2027 (USD Million)
Table 16 North America: Prescriptive Analytics Market, by Country, 2020-2027 (USD Million)
Table 17 Europe: Prescriptive Analytics Market, by Country, 2020-2027 (USD Million)
Table 18 Asia-Pacific: Prescriptive Analytics Market, by Country, 2020-2027 (USD Million)
7 Life Science Analytics Market, by Application
7.1 Introduction
Table 19 Global Market, by Application, 2020-2027 (USD Million)
7.2 Research & Development
Table 20 Global Market: Commercially Available R&D Solutions
Table 21 Global Market for Research & Development, by Region, 2020-2027 (USD Million)
Table 22 North America: Market for Research & Development, by Country, 2020-2027 (USD Million)
Table 23 Europe: Market for Research & Development, by Country, 2020-2027 (USD Million)
Table 24 Asia-Pacific: Market for Research & Development, by Country, 2020-2027 (USD Million)
Table 25 Global Market for Research & Development, by Type, 2020-2027 (USD Million)
7.2.1 Clinical Trials
7.2.1.1 Rising Need to Streamline Clinical Data and Reduce Time & Costs to Drive Market
Table 26 Global Market: Commercially Available Clinical Trial Solutions
Table 27 Global Market for Clinical Trials, by Region, 2020-2027 (USD Million)
Table 28 North America: Market for Clinical Trials, by Country, 2020-2027 (USD Million)
Table 29 Europe: Market for Clinical Trials, by Country, 2020-2027 (USD Million)
Table 30 Asia-Pacific: Market for Clinical Trials, by Country, 2020-2027 (USD Million)
7.2.2 Preclinical Trials
7.2.2.1 Ability to Assist Researchers in Process Innovation and Decision Support to Drive Adoption
Table 31 Global Market: Commercially Available Preclinical Trial Solutions
Table 32 Global Market for Preclinical Trials, by Region, 2020-2027 (USD Million)
Table 33 North America: Market for Preclinical Trials, by Country, 2020-2027 (USD Million)
Table 34 Europe: Market for Preclinical Trials, by Country, 2020-2027 (USD Million)
Table 35 Asia-Pacific: Market for Preclinical Trials, by Country, 2020-2027 (USD Million)
7.3 Sales & Marketing
7.3.1 Rising Analysis of Digital Marketing Effectiveness to Drive Adoption
Table 36 Life Science Analytics Market: Commercially Available Sales & Marketing Solutions
Table 37 Global Market for Sales & Marketing, by Region, 2020-2027 (USD Million)
Table 38 North America: Market for Sales & Marketing, by Country, 2020-2027 (USD Million)
Table 39 Europe: Market for Sales & Marketing, by Country, 2020-2027(USD Million)
Table 40 Asia-Pacific: Market for Sales & Marketing, by Country, 2020-2027 (USD Million)
7.4 Pharmacovigilance
7.4.1 Monitoring of Drug Trials and Medication Programs to Fuel Market Uptake
Table 41 Global Market: Commercially Available Pharmacovigilance Solutions
Table 42 Global Market for Pharmacovigilance, by Region, 2020-2027 (USD Million)
Table 43 North America: Market for Pharmacovigilance, by Country, 2020-2027 (USD Million)
Table 44 Europe: Market for Pharmacovigilance, by Country, 2020-2027 (USD Million)
Table 45 Asia-Pacific: Market for Pharmacovigilance, by Country, 2020-2027 (USD Million)
7.5 Regulatory Compliance
7.5.1 Stringent Requirements for Compliance Adherence to Drive Adoption of Solutions
Table 46 Global Market: Commercially Available Regulatory Compliance Solutions
Table 47 Global Market for Regulatory Compliance, by Region, 2020-2027 (USD Million)
Table 48 North America: Market for Regulatory Compliance, by Country, 2020-2027(USD Million)
Table 49 Europe: Market for Regulatory Compliance, by Country, 2020-2027 (USD Million)
Table 50 Asia-Pacific: Market for Regulatory Compliance, by Country, 2020-2027 (USD Million)
7.6 Supply Chain Optimization
7.6.1 Rising Need to Reduce Logistics Costs to Support Market Growth
Table 51 Global Market: Commercially Available Supply Chain Optimization Solutions
Table 52 Global Market for Supply Chain Optimization, by Region, 2020-2027 (USD Million)
Table 53 North America: Market for Supply Chain Optimization, by Country, 2020-2027 (USD Million)
Table 54 Europe: Market for Supply Chain Optimization, by Country, 2020-2027 (USD Million)
Table 55 Asia-Pacific: Market for Supply Chain Optimization, by Country, 2020-2027 (USD Million)
8 Life Science Analytics Market, by Component
8.1 Introduction
Table 56 Global Market, by Component, 2020-2027(USD Million)
8.2 Services
8.2.1 Increasing Utilization of Service Providers for Implementation and Maintenance of Analytics to Drive Market
Table 57 Life Science Analytics Services Market, by Region, 2020-2027 (USD Million)
Table 58 North America: Life Science Analytics Services Market, by Country, 2020-2027 (USD Million)
Table 59 Europe: Life Science Analytics Services Market, by Country, 2020-2027 (USD Million)
Table 60 Asia-Pacific: Life Science Analytics Services Market, by Country, 2020-2027 (USD Million)
8.3 Software
8.3.1 Rising Need to Manage Clinical Trials Data by Pharma-Biotech Companies to Drive Adoption
Table 61 Life Science Analytics Software Market, by Region, 2020-2027 (USD Million)
Table 62 North America: Life Science Analytics Software Market, by Country, 2020-2027 (USD Million)
Table 63 Europe: Life Science Analytics Software Market, by Country, 2020-2027 (USD Million)
Table 64 Asia-Pacific: Life Science Analytics Software Market, by Country, 2020-2027 (USD Million)
9 Life Science Analytics Market, by Delivery Model
9.1 Introduction
Table 65 Global Market, by Delivery Model, 2020-2027 (USD Million)
9.2 On-Premise Delivery Model
9.2.1 Provision of Multi-Vendor Architecture and Security Benefits to Drive Market
Table 66 Global Market for On-Premise Delivery Model, by Region, 2020-2027 (USD Million)
Table 67 North America: Life Science Analytics Solutions Market for On-Premise Delivery Model, by Country, 2020-2027 (USD Million)
Table 68 Europe: Life Science Analytics Solutions Market for On-Premise Delivery Model, by Country, 2020-2027 (USD Million)
Table 69 Asia-Pacific: Life Science Analytics Solutions Market for On-Premise Delivery Model, by Country, 2020-2027 (USD Million)
9.3 On-Demand Delivery Model
9.3.1 Real-Time Analysis and Elimination of Purchasing Costs for Software & Hardware to Drive Adoption
Table 70 Global Market: On-Demand Solutions Offered
Table 71 Life Science Analytics Solutions Market for On-Demand Delivery Model, by Region, 2020-2027 (USD Million)
Table 72 North America: Life Science Analytics Solutions Market for On-Demand Delivery Model, by Country, 2020-2027 (USD Million)
Table 73 Europe: Life Science Analytics Solutions Market for On-Demand Delivery Model, by Country, 2020-2027 (USD Million)
Table 74 Asia-Pacific: Life Science Analytics Solutions Market for On-Demand Delivery Model, by Country, 2020-2027 (USD Million)
10 Life Science Analytics Market, by End-user
10.1 Introduction
Table 75 Global Market, by End-user, 2020-2027 (USD Million)
10.2 Pharmaceutical & Biotechnology Companies
10.2.1 Rising Need for Innovative Therapies to Adopt Analytics for Product Development
Table 76 Global Market for Pharmaceutical & Biotechnology Companies, by Region, 2020-2027 (USD Million)
Table 77 North America: Market for Pharmaceutical & Biotechnology Companies, by Country, 2020-2027 (USD Million)
Table 78 Europe: Market for Pharmaceutical & Biotechnology Companies, by Country, 2020-2027 (USD Million)
Table 79 Asia-Pacific: Market for Pharmaceutical & Biotechnology Companies, by Country, 2020-2027 (USD Million)
10.3 Medical Device Companies
10.3.1 Adoption of Big Data Analytics for Commercialization of Devices to Drive Market
Table 80 Global Market: Key Solutions Offered by Companies
Table 81 Global Market for Medical Device Companies, by Region, 2020-2027 (USD Million)
Table 82 North America: Market for Medical Device Companies, by Country, 2020-2027 (USD Million)
Table 83 Europe: Market for Medical Device Companies, by Country, 2020-2027 (USD Million)
Table 84 Asia-Pacific: Market for Medical Device Companies, by Country, 2020-2027 (USD Million)
10.4 Research Centers
10.4.1 Analyzation of Large Volumes of Data due to Increasing Research Activities to Support Market Growth
Table 85 Global Market for Research Centers, by Region, 2020-2027 (USD Million)
Table 86 North America: Market for Research Centers, by Country, 2020-2027 (USD Million)
Table 87 Europe: Market for Research Centers, by Country, 2020-2027 (USD Million)
Table 88 Asia-Pacific: Market for Research Centers, by Country, 2020-2027 (USD Million)
10.5 Third-Party Administrators (Tpas)
10.5.1 Rising R&D Outsourcing by Life Science Companies to Drive Market Growth
Table 89 Global Market for Third-Party Administrators, by Region, 2020-2027 (USD Million)
Table 90 North America: Market for Third-Party Administrators, by Country, 2020-2027 (USD Million)
Table 91 Europe: Market for Third-Party Administrators, by Country, 2020-2027 (USD Million)
Table 92 Asia-Pacific: Market for Third-Party Administrators, by Country, 2020-2027 (USD Million)
11 Life Science Analytics Market, by Region
11.1 Introduction
Table 93 Global Market, by Region, 2020-2027 (USD Million)
11.2 North America
Figure 27 North America: Life Science Analytics Market Snapshot
11.2.1 North America: Recession Impact Analysis
Table 94 North America: Market, by Country, 2020-2027 (USD Million)
Table 95 North America: Market, by Type, 2020-2027 (USD Million)
Table 96 North America: Market, by Application, 2020-2027 (USD Million)
Table 97 North America: Market for Research & Development Applications, by Type, 2020-2027 (USD Million)
Table 98 North America: Market, by Component, 2020-2027 (USD Million)
Table 99 North America: Market, by Delivery Model, 2020-2027 (USD Million)
Table 100 North America: Market, by End-user, 2020-2027 (USD Million)
11.2.2 US
11.2.2.1 Established Economy and Increasing R&D Expenditure to Drive Adoption of Analytical Solutions
Table 101 US: Life Science Analytics Market, by Type, 2020-2027 (USD Million)
Table 102 US: Market, by Application, 2020-2027 (USD Million)
Table 103 US: Market for Research & Development Applications, by Type, 2020-2027 (USD Million)
Table 104 US: Market, by Component, 2020-2027 (USD Million)
Table 105 US: Market, by Delivery Model, 2020-2027 (USD Million)
Table 106 US: Market, by End-user, 2020-2027 (USD Million)
11.2.3 Canada
11.2.3.1 Rising Need for Data Standardization in Life Sciences to Fuel Uptake
Table 107 Canada: Life Science Analytics Market, by Type, 2020-2027 (USD Million)
Table 108 Canada: Market, by Application, 2020-2027 (USD Million)
Table 109 Canada: Market for Research & Development Applications, by Type, 2020-2027 (USD Million)
Table 110 Canada: Market, by Component, 2020-2027 (USD Million)
Table 111 Canada: Market, by Delivery Model, 2020-2027 (USD Million)
Table 112 Canada: Market, by End-user, 2020-2027 (USD Million)
11.3 Europe
11.3.1 Europe: Recession Impact Analysis
Table 113 Europe: Life Science Analytics Market, by Country, 2020-2027 (USD Million)
Table 114 Europe: Market, by Type, 2020-2027 (USD Million)
Table 115 Europe: Market, by Application, 2020-2027 (USD Million)
Table 116 Europe: Market for Research & Development Applications, by Type, 2020-2027 (USD Million)
Table 117 Europe: Market, by Component, 2020-2027 (USD Million)
Table 118 Europe: Market, by Delivery Model, 2020-2027 (USD Million)
Table 119 Europe: Market, by End-user, 2020-2027 (USD Million)
11.3.2 Germany
11.3.2.1 Growing R&D Investments by Pharmaceutical & Biotechnology Companies to Drive Market
Table 120 Germany: Life Science Analytics Market, by Type, 2020-2027 (USD Million)
Table 121 Germany: Market, by Application, 2020-2027 (USD Million)
Table 122 Germany: Market for Research & Development Applications, by Type, 2020-2027 (USD Million)
Table 123 Germany: Market, by Component, 2020-2027 (USD Million)
Table 124 Germany: Market, by Delivery Model, 2020-2027 (USD Million)
Table 125 Germany: Market, by End-user, 2020-2027 (USD Million)
11.3.3 France
11.3.3.1 Growing Government Support for Adoption of Ai & Big Data Analytics to Drive Market
Table 126 France: Life Science Analytics Market, by Type, 2020-2027 (USD Million)
Table 127 France: Market, by Application, 2020-2027 (USD Million)
Table 128 France: Market for Research & Development Applications, by Type, 2020-2027 (USD Million)
Table 129 France: Market, by Component, 2020-2027 (USD Million)
Table 130 France: Market, by Delivery Model, 2020-2027(USD Million)
Table 131 France: Market, by End-user, 2020-2027 (USD Million)
11.3.4 UK
11.3.4.1 Growing Number of Clinical Trials to Drive Uptake of Life Science Analytics Solutions
Table 132 UK: Life Science Analytics Market, by Type, 2020-2027 (USD Million)
Table 133 UK: Market, by Application, 2020-2027 (USD Million)
Table 134 UK: Market for Research & Development Applications, by Type, 2020-2027 (USD Million)
Table 135 UK: Market, by Component, 2020-2027 (USD Million)
Table 136 UK: Market, by Delivery Model, 2020-2027 (USD Million)
Table 137 UK: Market, by End-user, 2020-2027 (USD Million)
11.3.5 Italy
11.3.5.1 Growing Number of Drug Approvals to Drive Uptake of Analytics Solutions
Table 138 Italy: Life Science Analytics Market, by Type, 2020-2027 (USD Million)
Table 139 Italy: Market, by Application, 2020-2027 (USD Million)
Table 140 Italy: Market for Research & Development Applications, by Type, 2020-2027 (USD Million)
Table 141 Italy: Market, by Component, 2020-2027 (USD Million)
Table 142 Italy: Market, by Delivery Model, 2020-2027(USD Million)
Table 143 Italy: Market, by End-user, 2020-2027 (USD Million)
11.3.6 Rest of Europe
Table 144 Rest of Europe: Life Science Analytics Market, by Type, 2020-2027 (USD Million)
Table 145 Rest of Europe: Market, by Application, 2020-2027 (USD Million)
Table 146 Rest of Europe: Market for Research & Development Applications, by Type, 2020-2027 (USD Million)
Table 147 Rest of Europe: Market, by Component, 2020-2027 (USD Million)
Table 148 Rest of Europe: Market, by Delivery Model, 2020-2027 (USD Million)
Table 149 Rest of Europe: Market, by End-user, 2020-2027 (USD Million)
11.4 Asia-Pacific
Figure 28 Asia-Pacific: Life Science Analytics Market Snapshot
11.4.1 Asia-Pacific: Recession Impact Analysis
Table 150 Asia-Pacific: Market, by Country, 2020-2027 (USD Million)
Table 151 Asia-Pacific: Market, by Type, 2020-2027 (USD Million)
Table 152 Asia-Pacific: Market, by Application, 2020-2027 (USD Million)
Table 153 Asia-Pacific: Market for Research & Development Applications, by Type, 2020-2027 (USD Million)
Table 154 Asia-Pacific: Market, by Component, 2020-2027 (USD Million)
Table 155 Asia-Pacific: Market, by Delivery Model, 2020-2027 (USD Million)
Table 156 Asia-Pacific: Market, by End-user, 2020-2027 (USD Million)
11.4.2 Japan
11.4.2.1 Growing Government Support for Clinical R&D Activities to Drive Adoption
Table 157 Japan: Life Science Analytics Market, by Type, 2020-2027 (USD Million)
Table 158 Japan: Market, by Application, 2020-2027 (USD Million)
Table 159 Japan: Market for Research and Development Applications, by Type, 2020-2027 (USD Million)
Table 160 Japan: Market, by Component, 2020-2027 (USD Million)
Table 161 Japan: Market, by Delivery Model, 2020-2027 (USD Million)
Table 162 Japan: Market, by End-user, 2020-2027 (USD Million)
11.4.3 China
11.4.3.1 Growth in Life Science Industry to Support Adoption of Solutions
Table 163 China: Life Science Analytics Market, by Type, 2020-2027 (USD Million)
Table 164 China: Market, by Application, 2020-2027 (USD Million)
Table 165 China: Market for Research & Development Applications, by Type, 2020-2027 (USD Million)
Table 166 China: Market, by Component, 2020-2027 (USD Million)
Table 167 China: Market, by Delivery Model, 2020-2027 (USD Million)
Table 168 China: Market, by End-user, 2020-2027 (USD Million)
11.4.4 India
11.4.4.1 Rising R&D Expenditure and Growing Number of Drug Development Activities to Support Market Growth
Table 169 India: Life Science Analytics Market, by Type, 2020-2027 (USD Million)
Table 170 India: Market, by Application, 2020-2027 (USD Million)
Table 171 India: Market for Research & Development Applications, by Type, 2020-2027 (USD Million)
Table 172 India: Market, by Component, 2020-2027 (USD Million)
Table 173 India: Market, by Delivery Model, 2020-2027 (USD Million)
Table 174 India: Market, by End-user, 2020-2027 (USD Million)
11.4.5 Rest of Asia-Pacific
Table 175 Rest of Asia-Pacific: Life Science Analytics Market, by Type, 2020-2027 (USD Million)
Table 176 Rest of Asia-Pacific: Market, by Application, 2020-2027 (USD Million)
Table 177 Rest of Asia-Pacific: Market for Research & Development Applications, by Type, 2020-2027 (USD Million)
Table 178 Rest of Asia-Pacific: Market, by Component, 2020-2027 (USD Million)
Table 179 Rest of Asia-Pacific: Market, by Delivery Model, 2020-2027 (USD Million)
Table 180 Rest of Asia-Pacific: Market, by End-user, 2020-2027 (USD Million)
11.5 Rest of the World
11.5.1 Rest of the World: Recession Impact Analysis
Table 181 Rest of the World: Life Science Analytics Market, by Type, 2020-2027 (USD Million)
Table 182 Rest of the World: Market, by Application, 2020-2027 (USD Million)
Table 183 Rest of the World: Market for Research and Development Applications, by Type, 2020-2027 (USD Million)
Table 184 Rest of the World: Market, by Component, 2020-2027 (USD Million)
Table 185 Rest of the World: Market, by Delivery Model, 2020-2027 (USD Million)
Table 186 Rest of the World: Market, by End-user, 2020-2027 (USD Million)
12 Competitive Landscape
12.1 Introduction
12.2 Strategies Adopted by Key Players
12.2.1 Overview of Strategies Adopted by Players
12.3 Revenue Share Analysis of Top Market Players
Figure 29 Life Science Analytics Market: Revenue Share Analysis of Key Players
12.4 Market Ranking Analysis, 2021
Figure 30 Global Market: Market Ranking Analysis (2021)
12.5 Competitive Leadership Mapping
12.5.1 Stars
12.5.2 Pervasive Players
12.5.3 Emerging Leaders
12.5.4 Participants
Figure 31 Competitive Leadership Mapping for Key Players (2021)
12.6 Competitive Leadership Mapping for Startups
12.6.1 Progressive Companies
12.6.2 Starting Blocks
12.6.3 Responsive Companies
12.6.4 Dynamic Companies
Figure 32 Competitive Leadership Mapping for Startups (2021)
12.7 Competitive Benchmarking
Table 187 Global Market: Overall Company Footprint
Table 188 Global Market: Application Footprint of Companies
Table 189 Global Market: Component Footprint of Companies
Table 190 Global Market: Regional Footprint of Companies
12.8 Competitive Scenario
12.8.1 Product/Service Launches/Enhancements
Table 191 Key Product/Service Launches/Enhancements (January 2019-December 2022)
12.8.2 Deals
Table 192 Deals (January 2019-December 2022)
12.8.3 Other Developments
Table 193 Other Developments (January 2019-December 2022)
13 Company Profiles
13.1 Key Players
(Business Overview, Products Offered, Recent Developments, and Analyst's View (Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 Oracle
Table 194 Oracle: Company Overview
Figure 33 Oracle: Company Snapshot (2022)
13.1.2 Ibm
Table 195 Ibm: Company Overview
Figure 34 Ibm: Company Snapshot (2021)
13.1.3 Sas Institute Inc.
Table 196 Sas Institute Inc.: Company Overview
Figure 35 Sas Institute Inc.: Company Snapshot (2021)
13.1.4 Accenture
Table 197 Accenture: Company Overview
Figure 36 Accenture: Company Snapshot (2021)
13.1.5 Iqvia Inc.
Table 198 Iqvia Inc.: Company Overview
Figure 37 Iqvia Inc.: Company Snapshot (2021)
13.1.6 Cognizant
Table 199 Cognizant: Company Overview
Figure 38 Cognizant: Company Snapshot (2021)
13.1.7 Wipro
Table 200 Wipro: Company Overview
Figure 39 Wipro: Company Snapshot (2022)
13.1.8 Allscripts Healthcare, LLC
Table 201 Allscripts Healthcare, LLC: Company Overview
Figure 40 Allscripts Healthcare, LLC: Company Snapshot (2021)
13.1.9 Optum, Inc.
Table 202 Optum, Inc.: Company Overview
Figure 41 Optum, Inc.: Company Snapshot (2021)
13.1.10 Microsoft
Table 203 Microsoft: Company Overview
Figure 42 Microsoft: Company Snapshot (2021)
13.1.11 Maxisit
Table 204 Maxisit: Company Overview
13.1.12 Exlservice Holdings, Inc.
Table 205 Exlservice Holdings, Inc.: Company Overview
Figure 43 Exlservice Holdings, Inc.: Company Snapshot (2021)
13.1.13 Cerner Corporation
Table 206 Cerner Corporation: Company Overview
Figure 44 Cerner Corporation: Company Snapshot (2021)
13.1.14 Inovalon
Table 207 Inovalon: Company Overview
13.1.15 Citiustech Inc.
Table 208 Citiustech Inc.: Company Overview
13.1.16 Saama Technologies, LLC
Table 209 Saama Technologies, LLC: Company Overview
13.1.17 Axtria
Table 210 Axtria: Company Overview
13.1.18 Clarivate
Table 211 Clarivate: Company Overview
Figure 45 Clarivate: Company Snapshot (2021)
13.2 Other Companies
13.2.1 Thoughtsphere
13.2.2 Thoughtspot, Inc.
13.2.3 Alteryx, Inc.
13.2.4 Sisense Inc.
13.2.5 Cotiviti, Inc.
13.2.6 Amazon Web Services, Inc.
13.2.7 Veeva Systems
*Details on Business Overview, Products Offered, Recent Developments, and Analyst's View (Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) Might Not be Captured in Case of Unlisted Companies.
14 Appendix
14.1 Discussion Guide
14.2 Knowledgestore: The Subscription Portal
14.3 Customization Options
Executive Summary
Companies Mentioned
- Accenture
- Allscripts Healthcare, LLC
- Alteryx, Inc.
- Amazon Web Services, Inc.
- Axtria
- Cerner Corporation
- Citiustech Inc.
- Clarivate
- Cognizant
- Cotiviti, Inc.
- Exlservice Holdings, Inc.
- Ibm
- Inovalon
- Iqvia Inc.
- Maxisit
- Microsoft
- Optum, Inc.
- Oracle
- Saama Technologies, LLC
- Sas Institute Inc.
- Sisense Inc.
- Thoughtsphere
- Thoughtspot, Inc.
- Veeva Systems
- Wipro
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 243 |
| Published | February 2023 |
| Forecast Period | 2022 - 2027 |
| Estimated Market Value ( USD | $ 27.1 Billion |
| Forecasted Market Value ( USD | $ 47.5 Billion |
| Compound Annual Growth Rate | 11.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
